Edition:
United Kingdom

YiChang HEC ChangJiang Pharmaceutical Co Ltd (1558.HK)

1558.HK on Hong Kong Stock

38.30HKD
25 Apr 2018
Change (% chg)

HK$0.80 (+2.13%)
Prev Close
HK$37.50
Open
HK$37.40
Day's High
HK$38.70
Day's Low
HK$36.70
Volume
619,400
Avg. Vol
2,393,720
52-wk High
HK$51.60
52-wk Low
HK$16.38

Latest Key Developments (Source: Significant Developments)

Yichang Hec Changjiang Pharmaceutical Co ‍Expects FY​ Profit Attributable To Rise At Least 70 Pct
Friday, 2 Feb 2018 

Feb 2 (Reuters) - Yichang Hec Changjiang Pharmaceutical Co Ltd <1558.HK>::‍EXPECTED THAT GROUP WILL RECORD A NO LESS THAN 70 PCT INCREASE IN ITS PROFIT ATTRIBUTABLE FOR FY​.EXPECTED RESULT DUE TO SIGNIFICANT INCREASE IN SALES VOLUME OF COMPANY'S KEY PRODUCT KEWEI.  Full Article

Yichang Hec Changjiang Pharmaceutical posts HY revenue of RMB662.3 mln
Friday, 18 Aug 2017 

Aug 18 (Reuters) - Yichang Hec Changjiang Pharmaceutical Co Ltd <1558.HK>:HY revenue was RMB662.3 million, representing an increase of 19.2 percent.HY profit & total comprehensive income attributable to equity shareholders of co was RMB301.9 million, up 40.4 percent.Board recommended an interim dividend of RMB0.40 per share (tax inclusive).  Full Article

Yichang Hec Changjiang Pharmaceutical ‍expects HY profit attributable to rise​
Wednesday, 19 Jul 2017 

July 19 (Reuters) - Yichang Hec Changjiang Pharmaceutical Co Ltd <1558.HK>::‍Expected that group will record an increase in profit attributable to equity shareholders of 40 pct for HY​.Expected result due to continuous improvement of academic promotion activities of co.  Full Article

Temasek's unit increases stake in Yichang Hec Changjiang Pharmaceutical to 7.64 pct- HKEx filing
Friday, 14 Jul 2017 

July 14 (Reuters) - Yichang Hec Changjiang Pharmaceutical Co Ltd <1558.HK>:Unit Of Singapore's Temasek bought 2.16 million shares in Yichang Hec Changjiang Pharmaceutical <<<1558.HK>>> at an average price of HK$18.0 per share on July 10- HKEx filing.Temasek unit's stake in Yichang Hec Changjiang Pharmaceutical increases to 7.64 percent after the transaction from 6.69 percent previously - HKEx filing.  Full Article

Temasek's unit acquires stake in Yichang Hec Changjiang Pharmaceutical - HKEx filing
Friday, 5 May 2017 

May 5 (Reuters) - Yichang Hec Changjiang Pharmaceutical Co Ltd <1558.HK>:Singapore's Temasek unit acquires 15.1 million shares of Yichang Hec Changjiang Pharmaceutical <<<1558.HK>>> an average price of HK$16.3 per share on April 27 for 6.69 percent stake - HKEx filing.  Full Article

Yichang HEC Changjiang Pharmaceutical gets clinical approvals from CFDA
Thursday, 4 May 2017 

May 4 (Reuters) - Yichang Hec Changjiang Pharmaceutical Co Ltd <1558.HK>:Clinical approvals successfully obtained from CFDA for insulin aspart drug substance and product.  Full Article

Unit of Singapore's GIC sells shares in Yichang Hec Changjiang Pharma
Wednesday, 12 Apr 2017 

Yichang Hec Changjiang Pharmaceutical Co Ltd <1558.HK> : GIC's unit has unloaded 277,400 shares in Yichang Hec Changjiang Pharmaceutical <1558.HK> at average HK$17 per share on April 7 - HKEx disclosure .GIC unit's long position in the company reduces to 8.95 percent from 9.07 percent after transaction - HKEx disclosure.  Full Article

Yichang Hec Changjiang Pharma signs equity transfer agreement with Taigen Biopharma
Monday, 27 Mar 2017 

Yichang Hec Changjiang Pharmaceutical Co Ltd <1558.HK>: Entered into equity transfer agreement with taigen biopharmaceuticals . Deal to acquire 9% equity interests in jv held by Taigen Biopharmaceuticals .Consideration of equity transfer will be US$40 million or US$20 million.  Full Article

Yichang Hec Changjiang Pharmaceutical enters into Projects Contracting Agreement with Yidu Construction
Friday, 24 Feb 2017 

Yichang Hec Changjiang Pharmaceutical Co Ltd <1558.HK> : Company entered into transactions framework agreements with parent company and/or shenzhen hec industrial .Co entered into projects contracting agreement with yidu construction for total consideration rmb225 million.  Full Article

Yichang Hec Changjiang Pharmaceutical Co expects to record a rise in net profit for FY2016
Tuesday, 7 Feb 2017 

Yichang Hec Changjiang Pharmaceutical Co Ltd <1558.HK> : Expected that group will record an increase in profit attributable to equity shareholders of not less than 40% for year ended 31 december 2016 .Expected growth in profit primarily attributed to increase in sales volume of kewei.  Full Article